| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ... Nature genetics 12 (3), 333-337, 1996 | 1147 | 1996 |
| Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci FR Schumacher, AA Al Olama, SI Berndt, S Benlloch, M Ahmed, ... Nature genetics 50 (7), 928-936, 2018 | 773 | 2018 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) N Mavaddat, D Barrowdale, IL Andrulis, SM Domchek, D Eccles, ... Cancer Epidemiology, Biomarkers & Prevention 21 (1), 134-147, 2012 | 758 | 2012 |
| Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, BY Karlan, ... Jama 307 (4), 382-389, 2012 | 732 | 2012 |
| Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer TR Rebbeck, N Mitra, F Wan, OM Sinilnikova, S Healey, L McGuffog, ... Jama 313 (13), 1347-1361, 2015 | 548 | 2015 |
| BRCA1 sequence analysis in women at high risk for susceptibility mutations: risk factor analysis and implications for genetic testing D Shattuck-Eidens, A Oliphant, M McClure, C McBride, J Gupte, T Rubano, ... Jama 278 (15), 1242-1250, 1997 | 507 | 1997 |
| Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. DF Easton, L Steele, P Fields, W Ormiston, D Averill, PA Daly, R McManus, ... American journal of human genetics 61 (1), 120, 1997 | 484 | 1997 |
| Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk FJ Couch, X Wang, L McGuffog, A Lee, C Olswold, KB Kuchenbaecker, ... PLoS genetics 9 (3), e1003212, 2013 | 329 | 2013 |
| Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction DV Conti, BF Darst, LC Moss, EJ Saunders, X Sheng, A Chou, ... Nature genetics 53 (1), 65-75, 2021 | 312 | 2021 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 307 | 2015 |
| Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations TR Rebbeck, TM Friebel, E Friedman, U Hamann, D Huo, A Kwong, ... Human mutation 39 (5), 593-620, 2018 | 291 | 2018 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 191 | 2017 |
| Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives SL Neuhausen, L Steele, S Ryan, M Mousavi, M Pinto, KE Osann, ... Journal of autoimmunity 31 (2), 160-165, 2008 | 181 | 2008 |
| Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States YC Ding, L Steele, CJ Kuan, S Greilac, SL Neuhausen Breast cancer research and treatment 126, 771-778, 2011 | 156 | 2011 |
| Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 V Silvestri, D Barrowdale, AM Mulligan, SL Neuhausen, S Fox, BY Karlan, ... Breast Cancer Research 18, 1-13, 2016 | 145 | 2016 |
| Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations DK Gaffney, RM Brohet, CM Lewis, JA Holden, SS Buys, SL Neuhausen, ... Radiotherapy and oncology 47 (2), 129-136, 1998 | 145 | 1998 |
| Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk N Orr, A Lemnrau, R Cooke, O Fletcher, K Tomczyk, M Jones, N Johnson, ... Nature genetics 44 (11), 1182-1184, 2012 | 120 | 2012 |
| Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants T Dadaev, EJ Saunders, PJ Newcombe, E Anokian, DA Leongamornlert, ... Nature communications 9 (1), 2256, 2018 | 99 | 2018 |
| A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer ES Ratner, FK Keane, R Lindner, RA Tassi, T Paranjape, M Glasgow, ... Oncogene 31 (42), 4559-4566, 2012 | 96 | 2012 |
| Genome-wide association study of celiac disease in North America confirms FRMD4B as new celiac locus C Garner, R Ahn, YC Ding, L Steele, S Stoven, PH Green, A Fasano, ... PloS one 9 (7), e101428, 2014 | 75 | 2014 |
